Your browser doesn't support javascript.
loading
Ethical considerations of using a single minor donor for three bone marrow harvests for three HLA-matched siblings with primary immunodeficiency.
Parikh, Suhag H; Pentz, Rebecca D; Haight, Ann; Adeli, Mehdi; Martin, Paul L; Driscoll, Timothy A; Page, Kristin; Kurtzberg, Joanne; Prasad, Vinod K; Barfield, Raymond C.
Afiliação
  • Parikh SH; Duke University Medical Center, Durham, North Carolina.
  • Pentz RD; Emory University, Atlanta, Georgia.
  • Haight A; Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, Georgia.
  • Adeli M; Hamad Medical Corporation, Doha, Qatar.
  • Martin PL; Duke University Medical Center, Durham, North Carolina.
  • Driscoll TA; Duke University Medical Center, Durham, North Carolina.
  • Page K; Duke University Medical Center, Durham, North Carolina.
  • Kurtzberg J; Duke University Medical Center, Durham, North Carolina.
  • Prasad VK; Duke University Medical Center, Durham, North Carolina.
  • Barfield RC; Duke University Medical Center, Durham, North Carolina.
Pediatr Blood Cancer ; 66(4): e27602, 2019 04.
Article em En | MEDLINE | ID: mdl-30609294
ABSTRACT
Allogeneic hematopoietic stem cell transplantation is curative for primary immunodeficiencies. Bone marrow from an unaffected human leukocyte antigen (HLA)-identical sibling donor is the ideal graft source. For minor donors, meaningful consent or assent may not be feasible, and permission from parents or legal guardians is considered acceptable. Adverse events, albeit extremely small, can be associated with bone marrow harvest in pediatric donors. Donor safety concerns potentially increase with multiple bone marrow harvests. Very little is known about multiple bone marrow harvests from pediatric donors. We describe the ethical considerations and clinical decision-making in an unusual clinical situation where three patients with the same primary immunodeficiency were HLA identical to one another and their younger sibling, who underwent bone marrow harvests three times between 1.3 and 4 years of age, resulting in successful transplantation for all three patients. We hope that this experience will provide guidance to providers and families in a similar situation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Medula Óssea / Transplante de Células-Tronco Hematopoéticas / Temas Bioéticos / Irmãos / Síndromes de Imunodeficiência Tipo de estudo: Guideline / Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Medula Óssea / Transplante de Células-Tronco Hematopoéticas / Temas Bioéticos / Irmãos / Síndromes de Imunodeficiência Tipo de estudo: Guideline / Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2019 Tipo de documento: Article